Fredun Pharmaceuticals share news, announcements and annual reports
NSE: FREDUNBSE: 539730Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,453.50.
30 Oct: open ₹1,455.00, high ₹1,467.90, low ₹1,360.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,310 Cr1,474th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.31
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.02%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.80
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 53,67255.3% delivered
Fredun Pharmaceuticals share news and announcements
665 announcements, routine notices left out, newest first. Page 2 of 14.
May 2026
Apr 2026
9 Apr · Board meeting
Meeting on 9 Apr 20269 Apr · Announcement under Regulation 30 (LODR)-Allotment
9 Apr · Announcement under Regulation 30 (LODR)-Conversion of Securities
Mar 2026
25 Mar · Announcement under Regulation 30 (LODR)-Meeting Updates
25 Mar · Announcement under Regulation 30 (LODR)-Allotment
25 Mar · Announcement under Regulation 30 (LODR)-Conversion of Securities
16 Mar · Announcement under Regulation 30 (LODR)-Meeting Updates
Feb 2026
16 Feb · Management
16 Feb · Meeting
16 Feb · Meeting
14 Feb · Business
9 Feb
Jan 2026
30 Jan · Board meeting
Meeting on 9 Feb 2026: quarterly results20 Jan · Meeting
19 Jan · Meeting
Dec 2025
29 Dec · Announcement under Regulation 30 (LODR)-Allotment
29 Dec · Announcement under Regulation 30 (LODR)-Allotment
17 Dec · Analysts
Nov 2025
28 Nov · Management